Neurocrine Biosciences, Inc. Net Income 2009–2025
Neurocrine Biosciences, Inc. reported $478.60M of net income for fiscal 2025. That was 40.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +17.5%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $478.60M | 16.7% | +40.2% |
| FY 2024 | $341.30M | 14.5% | +36.7% |
| FY 2023 | $249.70M | 13.2% | +61.6% |
| FY 2022 | $154.50M | 10.4% | +72.4% |
| FY 2021 | $89.60M | 7.9% | -78.0% |
| FY 2020 | $407.30M | 38.9% | +1000.8% |
| FY 2019 | $37.00M | 4.7% | +75.4% |
| FY 2018 | $21.10M | 4.7% | +114.8% |
| FY 2017 | $-142.54M | -88.2% | -1.0% |
| FY 2016 | $-141.09M | -940.6% | -58.7% |
| FY 2015 | $-88.93M | -449.8% | -46.9% |
| FY 2014 | $-60.54M | — | -31.4% |
| FY 2013 | $-46.09M | -1579.0% | -1017.2% |
| FY 2012 | $5.03M | 9.5% | -86.6% |
| FY 2011 | $37.57M | 48.5% | +571.5% |
| FY 2010 | $-7.97M | -23.8% | +84.4% |
| FY 2009 | $-51.04M | -1728.3% | — |
Source: Neurocrine Biosciences, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open NBIX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Neurocrine Biosciences, Inc. reported $478.60M of net income for fiscal 2025. That was 40.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +17.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Neurocrine Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeNeurocrine Biosciences, Inc. — frequently asked questions
What is Neurocrine Biosciences, Inc.'s net income?
Neurocrine Biosciences, Inc. (NBIX) reported net income of $478.60M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Neurocrine Biosciences, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.